Business ❯Pharmaceutical Industry ❯Drug Manufacturing

Novo Nordisk

Market Impact Semaglutide Semaglutide Products

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

The FDA and Novo Nordisk are investigating the safety of fake Ozempic products following reports of adverse events.

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

Pioneers of Obesity Drugs Win Prestigious Lasker Award